Detalles de la búsqueda
1.
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Lancet Oncol
; 24(3): 228-238, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36858721
2.
Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study.
Lancet Oncol
; 23(6): 768-780, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489363
3.
Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases.
Prostate
; 79(14): 1683-1691, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31442327
4.
Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO).
BMC Cancer
; 19(1): 766, 2019 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31382926
5.
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.
BMC Cancer
; 16: 135, 2016 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26906039
6.
Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology.
Clin Transl Oncol
; 26(1): 98-108, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37316754
7.
Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial.
Clin Transl Oncol
; 26(6): 1532-1538, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38102374
8.
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
J Clin Oncol
; 42(11): 1222-1228, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38227898
9.
Management of adverse events of targeted therapies in normal and special patients with metastatic renal cell carcinoma.
Cancer Metastasis Rev
; 31 Suppl 1: S19-27, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22821550
10.
SEOM SOGUG clinical guideline for treatment of kidney cancer (2022).
Clin Transl Oncol
; 25(9): 2732-2748, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37556095
11.
Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study.
Cancers (Basel)
; 15(21)2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37958398
12.
Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO).
J Clin Oncol
; 41(14): 2493-2502, 2023 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36809050
13.
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.
Front Oncol
; 13: 1223282, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37664025
14.
Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.
Front Oncol
; 13: 1343027, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38495081
15.
Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib.
Clin Genitourin Cancer
; 21(3): e166-e174, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610891
16.
Measures to evaluate quality of care in renal cancer: results of a Delphi study in Spain.
Clin Transl Oncol
; 24(3): 495-502, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34482526
17.
Expert recommendations on the management of patients with metastatic castration-resistant prostate cancer who progress after CHAARTED or LATITUDE.
Ther Adv Med Oncol
; 12: 1758835920920067, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33014145
18.
Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer.
J Clin Med
; 8(12)2019 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31766715
19.
Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma.
BMC Pharmacol Toxicol
; 19(1): 77, 2018 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30477570
20.
Circulating Tumor Cells as a Biomarker of Survival and Response to Radium-223 Therapy: Experience in a Cohort of Patients With Metastatic Castration-Resistant Prostate Cancer.
Clin Genitourin Cancer
; 16(6): e1133-e1139, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30104161